Dr. Shazia Zafar, MD

Dr. Zafar practices at Shazia Zafar MD in Pembroke Pines, Florida.

Dr. Zafar's NPI, 1053522862, was assigned on May 24, 2007. Dr. Zafar graduated from Rawalpindi Medical College in 2000. Dr. Zafar holds Florida license ME95785.

Dr. Zafar's primary practice is Shazia Zafar MD, at 1000 N Hiatus Rd, Pembroke Pines, FL 33026 in Broward County. The practice phone is (954) 883-2500.

Dr. Zafar's primary practice is Shazia Zafar MD in Pembroke Pines, Florida. Dmand AI also links Dr. Zafar to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zafar practices. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Zafar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Zafar is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Zafar's licenses on file in 2 states: Florida and Iowa.

Dmand AI lists arterial blot clot /embolism, breast cancer, chronic anemia, chronic embolism thrombosis, colorectal cancer, deep vein thrombosis (DVT), lung cancer and multiple myeloma among the conditions Dr. Zafar treats.

CMS data shows 69,005 Medicare services from Dr. Zafar across 10 procedure codes in 2024, for 74 Medicare patients. Medicare paid $117,404 for them. Every service was in an office.

CMS counts 74 Medicare patients who saw Dr. Zafar in 2024. The largest group is 65 to 74, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 36% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zafar's median patient age at 72, with 64% women.

In 2024, Dr. Zafar wrote 1,685 Medicare Part D claims for 227 patients. 64% of them were for generic drugs. CMS names the drug for 1,509 of them, across 34 drugs with 11 or more claims each, at $2,829,512 in total drug cost. In 2023, CMS named 1,027 claims across 27 drugs.

Dr. Zafar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Zafar as offering telehealth.

Dmand AI links 7 papers to Dr. Zafar, published from 2020 to 2022. 2022 was the busiest year, with 3. The most frequent topics are United Kingdom, Palliative Care and Qualitative Research. Dr. Zafar has published most often in BMC Palliat Care.

CMS Open Payments shows 351 general payments to Dr. Zafar from 54 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Pfizer Inc. paid the most, $856.

Dr. Zafar graduated from Rawalpindi Medical College in 2000. Dr. Zafar is a member of ASCO.

Dr. Zafar is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.